Atea Pharmaceuticals, Inc. - AVIR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$342.1M
QoQ value delta ($000)
+$138.7M (+68.18%)
Implied price effect (QoQ)
+46.4%
Shares
Total shares
65,482,331
QoQ shares delta
+8,480,363 (+14.88%)
Total shares held by funds (by quarter)

Market chart (AVIR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 127 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 64,295 11,950,772 0.0%
BlackRock, Inc. 45,382 8,435,437 0.0%
BML Capital Management, LLC 37,975 7,058,657 24.38%
TANG CAPITAL MANAGEMENT LLC 25,903 4,814,700 1.32%
VANGUARD CAPITAL MANAGEMENT LLC 17,464 3,246,124 0.0%
VANGUARD GROUP INC 15,090 4,227,110 0.0%
Bain Capital Life Sciences Investors, LLC 12,700 2,360,638 1.15%
TWO SIGMA INVESTMENTS, LP 10,029 1,864,164 0.01%
GEODE CAPITAL MANAGEMENT, LLC 9,405 1,747,706 0.0%
STATE STREET CORP 9,117 1,694,635 0.0%
ACADIAN ASSET MANAGEMENT LLC 8,508 1,582,817 0.01%
DIMENSIONAL FUND ADVISORS LP 6,752 1,255,484 0.0%
Rosalind Advisors, Inc. 6,304 1,171,855 2.53%
RENAISSANCE TECHNOLOGIES LLC 6,275 1,166,400 0.01%
JPMORGAN CHASE & CO 4,775 940,157 0.0%
MORGAN STANLEY 3,932 731,020 0.0%
TWO SIGMA ADVISERS, LP 3,783 1,059,700 0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3,210 596,709 0.0%
GOLDMAN SACHS GROUP INC 3,165 588,463 0.0%
NORTHERN TRUST CORP 3,147 585,025 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 2,999 557,579 0.0%
VANGUARD FIDUCIARY TRUST CO 2,607 484,705 0.0%
JANE STREET GROUP, LLC 2,250 418,296 0.0%
D. E. Shaw & Co., Inc. 2,040 379,314 0.0%
CM Management, LLC 1,909 355,000 1.6%